Tempest Therapeutics, Inc. (NASDAQ:TPST) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carol G. Gallagher Other companies: TRex Bio, Inc. (Lead Independent Director · Since at least Nov 5, 2026); PMV Pharmaceuticals, Inc. (Director · Since at least Nov 3, 2022); Atara Biotherapeutics, Inc. (Director · Since at least Jun 27, 2019); Certara, Inc. (Director · Jun 15, 2021 – Jun 15, 2021 · Past); Frazier Lifesciences Acquisition Corp (Director · Dec 8, 2020 – Nov 22, 2022 · Past); Metacrine Inc (Director · Sep 15, 2020 – Sep 15, 2020 · Past); Annexon, Inc. (Director · Jul 23, 2020 – Jul 23, 2020 · Past); Turning Point Therapeutics Inc (Director · Jul 24, 2019 – Aug 17, 2022 · Past) | Director · Jun 20, 2019 – Jun 22, 2020 · Past |
| Mary Lynne Hedley Other companies: Eli Lilly and Company (Director · Since at least May 15, 2022); Centessa Pharmaceuticals PLC (Director · Since at least May 27, 2021); Veeva Systems Inc. (Director · Since at least Aug 16, 2019); Bluebird bio Inc (Director · Sep 18, 2017 – Jun 20, 2018 · Past); Receptos Inc (Director · Apr 11, 2014 – Aug 27, 2015 · Past); Tesaro Inc (President & COO, Director · Jun 27, 2012 – Jan 22, 2019 · Past); Abraxis BioScience Inc (Executive VP of Ops & CSO · Jul 9, 2009 – Jul 13, 2009 · Past) | Director · Dec 7, 2018 – Jun 22, 2020 · Past |
| Richard Aldrich Other companies: KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 3, 2018 · Past); Concert Pharmaceuticals Inc (Director · Feb 12, 2014 – Mar 6, 2023 · Past); PTC Therapeutics, Inc. (Director · Mar 7, 2013 – Jun 8, 2015 · Past); Verastem, Inc. (Director · Jan 26, 2012 – Jun 10, 2014 · Past) | Director · Jun 11, 2012 – Dec 7, 2018 · Past |
| Tamara L Joseph Other companies: Spero Therapeutics, Inc. (Chief Legal Officer · Dec 2, 2020 – Feb 1, 2024 · Past); InVivo Therapeutics Holdings Corp (SVP, General Counsel · Mar 24, 2014 – Jan 18, 2017 · Past); Cubist Pharmaceuticals Inc (SVP, GC & Secretary · Apr 30, 2008 – Jun 29, 2012 · Past) | General Counsel and Secretary · Aug 19, 2019 – May 25, 2020 · Past |
| David Harding Other companies: T2 Biosystems, Inc. (Chief Commercial Officer · Oct 30, 2015 – Feb 9, 2017 · Past); Hologic Inc (Group VP & GM, Women's Health · Jun 28, 2013 – Nov 18, 2013 · Past) | Chief Commercial Officer · Apr 10, 2014 – Dec 9, 2014 · Past |
| Jeffrey E Young Other companies: Harvard Apparatus Regenerative Technology Inc (Director · Nov 6, 2018 – Jun 25, 2020 · Past); Juniper Pharmaceuticals Inc (Chief Financial Officer · Jan 1, 2017 – Aug 14, 2018 · Past) | Chief Financial Officer · Sep 8, 2014 – Dec 3, 2015 · Past |
| Michael Raab Other companies: Ardelyx, Inc. (President & CEO, Director · Since at least Jan 19, 2017); Amicus Therapeutics Inc (Director · Since at least Jun 9, 2016) | Director · Since at least Jun 25, 2021 |
| Thomas Malley Other companies: Kiniksa Pharmaceuticals International, plc (Director · Since at least May 23, 2018); Kura Oncology, Inc. (Director · Since at least Oct 13, 2015) | Director · Jun 30, 2015 – Jun 13, 2017 · Past |
| Christophe Couturier Other companies: Avantor, Inc. (EVP, AMEA · Since at least May 16, 2019) | Chief Financial Officer · Sep 6, 2016 – Mar 2, 2017 · Past |
| John Yee Other companies: Apnimed, Inc. (Senior Vice President, Medical Affairs · Since at least Nov 5, 2026) | Director · Since at least Jun 4, 2026 |
| Julia C Owens Other companies: Metacrine Inc (Director · Apr 1, 2021 – May 18, 2022 · Past) | Executive Chair, Director · Dec 7, 2018 – Mar 17, 2021 · Past |
| Louis J Arcudi III Other companies: Aceragen Inc. (Chief Financial Officer · Jan 3, 2017 – Aug 13, 2018 · Past) | President and CEO, Director · Dec 7, 2018 – Feb 26, 2021 · Past |
| Matthew Angel Other companies: Ernexa Therapeutics Inc. (President and CEO, Director · May 26, 2022 – Jan 12, 2023 · Past) | CEO and President, Director · Since at least Feb 3, 2026 |
| Pharis Mohideen Other companies: DBV Technologies SA (Chief Medical Officer · Since at least Jan 1, 2021) | Chief Medical Officer · Dec 7, 2018 – Jan 15, 2019 · Past |
| Randall W Whitcomb Other companies: Insmed Incorporated (Director · Jan 10, 2014 – Mar 10, 2015 · Past) | Director · Dec 7, 2018 – Jun 20, 2019 · Past |
| Thomas W Dubensky Other companies: Aduro Biotech Inc (Chief Scientific Officer · Apr 14, 2015 – Aug 10, 2017 · Past) | President, Director · Jun 25, 2021 – Jan 3, 2023 · Past |
| Andrew Fang | Head of Business Development · Since at least May 14, 2026 |
| Geoffrey Nichol | Director · Since at least Jun 13, 2024 |
| John W. Frederick | Board Member · Since at least Oct 14, 2026 |
| Justin Trojanowski | Corporate Controller · Since at least Sep 30, 2022 |
| Nancy Freda-Smith | Board Member · Since at least Sep 23, 2026 |
| Ronit Simantov | Director · Since at least Jan 27, 2026 |
| Samuel Whiting | Chief Medical Officer · Jun 25, 2021 – Jan 2, 2025 · Past |
| Sam Whiting | Chief Medical Officer · Aug 13, 2025 – Nov 4, 2026 · Past |
| Theresa McNeely | EVP, Chief Comm. Officer · Dec 9, 2014 – Apr 8, 2015 · Past |
| William Drake Richey | Director · Since at least Jun 4, 2026 |